Sep 29, 2022 / Presentations Analysis of Part D data on drug rebates and discounts Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing
Jul 19, 2022 / Data Book July 2022 Data Book: Health Care Spending and the Medicare Program Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jul 19, 2022 / Data Book July 2022 Data Book, Section 10: Prescription drugs Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans
Jun 15, 2022 / Reports June 2022 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jun 15, 2022 / Chapters Executive summary (June 2022 report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jun 15, 2022 / Chapters Chapter 7: Segmentation in the stand-alone Part D plan market (June 2022 report) Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests
Jun 15, 2022 / Chapters Appendix A: Commissioners’ voting on recommendations (June 2022 report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues
Jun 15, 2022 / Press Releases MedPAC releases June 2022 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues
Apr 07, 2022 / Presentations Segmentation in the stand-alone Part D prescription drug plan market Research Areas: Drugs, Devices, and Tests
Apr 07, 2022 / Presentations Initial findings from MedPAC’s analysis of Part D data on drug rebates and discounts Research Areas: Drugs, Devices, and Tests